v3.25.4
Consolidated statements of income - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue:      
Healthcare services € 13,097,267 € 13,471,363 € 14,166,796
Healthcare products 4,413,625 4,250,522 4,059,681
Insurance contracts 2,116,710 1,614,024 1,227,140
Revenue 19,627,602 19,335,909 19,453,617
Costs of revenue:      
Healthcare services 10,134,231 10,555,770 10,993,302
Healthcare products 2,399,741 2,419,939 2,349,766
Insurance contracts 2,064,701 1,603,548 1,185,544
Costs of revenue 14,598,673 14,579,257 14,528,612
Operating (income) expenses:      
Selling, general and administrative 3,032,728 3,142,819 3,196,336
Research and development 157,975 183,493 231,970
Income from equity method investees (181,368) (134,875) (121,785)
Other operating income (528,099) (760,118) (515,247)
Other operating expense 720,657 932,938 764,293
Operating income 1,827,036 1,392,395 1,369,438
Other (income) expense:      
Interest income (69,611) (71,575) (88,217)
Interest expense 384,409 407,044 424,640
Income before income taxes 1,512,238 1,056,926 1,033,015
Income tax expense 320,971 316,056 300,557
Net income 1,191,267 740,870 732,458
Net income attributable to noncontrolling interests 212,900 202,957 233,461
Net income attributable to shareholders of FME AG € 978,367 € 537,913 € 498,997
Basic earnings per share € 3.36 € 1.83 € 1.7
Diluted earnings per share € 3.36 € 1.83 € 1.7